
News
Newsletter Signup
Signup to get access to our regular monthly EU Insights newsletter and stay up to date with all the latest from PAREA.
Irish Doctors for Psychedelic Assisted Therapy joins as the latest Community Supporter
We are happy to officially welcome Irish Doctors for Psychedelic Assisted Therapy (IDPAT) as PAREA’s newest Community Supporter!
PAREA receives €50,000 grant from Entheon Foundation to advance psychedelic-assisted mental health treatments in Europe
PAREA has received a generous €50,000 grant from the Entheon Foundation, recognising our work to integrate psychedelic-assisted mental health treatments into Europe’s healthcare systems.
New expert commentary outlines five priorities to advance psychedelic therapies in mental health care
A new expert commentary is outlining five priorities to advance psychedelic therapies in mental health care. Published on The Mental Elf—an online resource on mental health research—the piece follows the 2024 IMHRF webinar “Making sense of psychedelics: Where is the field and where does it need to go?”
Europe Invests in the Future of Psychedelic Science: INTEGRATE Doctoral Network Launches with €4.3 Million in Funding
A second major EU-funded project in psychedelic science, following PsyPal, will start in the coming months. INTEGRATE will be a doctoral training network supported by €4.3 million in EU funding through the Marie Skłodowska-Curie Actions.
Welcoming Nico Gusac to the PAREA team
PAREA is delighted to welcome Nico Gusac as our new Communications Officer!
Health4Europe – a Blueprint for Health in the next Long Term EU Budget
Today, the EU4Health Civil Society Alliance launched Health4Europe—a strategic blueprint for the next EU Health Programme. Its goal is to ensure that health remains a top political and financial priority in the upcoming Multiannual Financial Framework (MFF), and to further strengthen the European Health Union.
New Era for Psychedelic Science in the Nordic Region: The Launch of the Nordic Psychedelic Network Initiative
On Wednesday, February 26th, 2025, a significant milestone was reached in the evolution of psychedelic science and medicine in the Nordic region. In Reykjavik, Iceland, during the conference Psychedelics as Medicine, representatives from all the Nordic psychedelic associations came together for an unprecedented moment of unity.
PAREA Participation in Psychedelic Science 2025
PAREA will be present next week at Psychedelic Science 2025, in Denver, Colorado!
PAREA’s response to the EU Biotech Act to Unlock Mental-Health Innovation
PAREA has submitted a response to the European Commission’s open call for evidence on the EU Biotech Act: “Shaping the EU Biotech Act to Unlock Mental-Health Innovation”. We welcome this ambition, which has highlighted mental health as a critical priority.
EUDA drug report highlights trends and developments in psychedelics
The EU Drugs Agency (EUDA) has released its annual European Drug Report, focusing on emerging trends in the European drug market. It includes a chapter on the growing interest in psychedelics for therapeutic use.
Czech Republic opens door to psychedelic therapy for mental health conditions
The Czech Parliament has passed a significant law allowing psilocybin therapy for mental health conditions like depression, anxiety, and addiction.
WHO releases rapid communication on controlled medicines guideline
The World Health Organization (WHO) has issued a rapid communication on its forthcoming guideline on controlled medicines, designed to support national policies that strike a balance between access and safety. PAREA was honoured to be invited to join the External Review Group for this new guideline.
New EU-funded network to support psychedelic research across Europe
A new European research network focused on psychedelics has been approved for funding under the COST (European Cooperation in Science and Technology) programme.
“Leading not Lagging” - PAREA launches policy paper urging Europe to lead on mental health innovation
New PAREA Policy Paper: “Leading, not Lagging: Putting Mental Health at the Core of Europe’s Innovation and Competitiveness Agenda.”
Portugal launches multidisciplinary clinical guidance on psychedelic therapies
On May 12, the Champalimaud Foundation hosted the official launch of Portugal’s Multidisciplinary Recommendations on the Clinical Use of Psychedelic Substances.
PAREA at Breaking Convention 2025
In April, PAREA Project Officer Francisca Silva took part in Breaking Convention - one of Europe’s largest and most diverse conferences on psychedelic research.
PAREA at the PsyPal workshop in Barcelona
As part of the EU-funded PsyPal project, our Founder and Executive Director, Tadeusz Hawrot, recently participated in a two-day Design Thinking Workshop hosted by IESE Business School in Barcelona.
Making mental health a strategic pillar of the EU life sciences agenda
PAREA has provided feedback on the European Commission’s initiative for a new multidisciplinary life sciences strategy, emphasising a clear message: mental health innovation should be a strategic priority on the agenda.
PAREA joins urgent call for action on EU4Health 2025 work programme
In a joint open letter from the EU4Health Civil Society Alliance (CSA) to Commission President Ursula von der Leyen, 35 organisations — including PAREA — urge the European Commission to take immediate action to secure stable and timely funding for health civil society organisations (CSOs).